Results 91 to 100 of about 46,120 (196)
A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence. [PDF]
Mosley SA +20 more
europepmc +1 more source
Varun Vaidya, Pranav PatelCollege of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, USABackground: Metoprolol, a selective beta-1 blocker, is available in two different salt forms in the market – metoprolol succinate ...
Vaidya V, Patel P
doaj
Background A robust and validated analytical method was developed for the simultaneous quantification of Efonidipine HCl Ethanolate and Metoprolol Succinate, which show a synergistic effect against thrombocytopenia.
Priyanka Malani +2 more
doaj +1 more source
Stable coronary heart disease treatment: focus on beta-adrenoblockers
Stable angina treatment with a prolonged-action beta-adrenoblocker, metoprolol succinate, is discussed. Themedication is effective, metabolically neutral, well tolerated and could also be used in patients with comorbidities.
V. I. Makolkin
doaj
Formulation and Evaluation of Metoprolol Succinate Extended Release Pellets. [PDF]
The present study is to develop a pharmaceutically stable and quality improved formulation of Metoprolol succinate extended release pellets. To achieve this goal various prototype formulation trials were formulated and the evaluated with respect to the ...
Abhishek, P
core
Correction to: Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation. [PDF]
Rivinius R +8 more
europepmc +1 more source
Metoprolol is a selective beta(1)-adrenergic antagonist extensively used in major fields of cardiology since 1975. Metoprolol has proven its efficacy in reducing cardiovascular events and mortality in patients with hypertension and coronary heart disease
Gudkov K.M., Kobalava Z.D.
core
Metoprolol-induced Psoriasiform Drug Eruption: A Case Report
Aim: We report the case of drug-induced psoriasiform eruptions in a middle aged known hypertensive and diabetic woman being treated for paroxysmal cardiac arrhythmias with metoprolol.
Umar Adamu +6 more
core +1 more source
100 patients with CHF functional class (FC) I against the background of hypertensive disease of stage II with regular left ventricular (LV) ejection fraction (EF) (LVEF≥55%) took part in the research and were randomized into two groups. Group 1 consisted
K. S. Bondarenko
doaj
100 patients with CHF FC III against the background of ischemic heart disease (IHD) and/or stage III hypertensive disease (HD) who received complex therapy (quinapril, torasemide, spironolactone) took part in the research.
E. S. Rokotyanskaya
doaj

